BioNTech SE: Form 20-F for the period ended Dec 31, 2019
Filed with the SEC on Mar 31, 2020 and accepted by EDGAR at Mar 31, 2020, 16:10 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | EUR 108.6m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | EUR 17.4m | ifrs-full:CostOfSales |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | EUR 91.2m | ifrs-full:GrossProfit |
| Operating income | 12 months2019-01-01 to 2019-12-31 | −EUR 181.5m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2019-01-01 to 2019-12-31 | −EUR 268.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2019-01-01 to 2019-12-31 | −EUR 179.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | −EUR 198.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | EUR 38.6m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2019-12-31 | EUR 519.1m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2019-12-31 | EUR 560.2m | ifrs-full:CurrentAssets |
| Total assets | At period end2019-12-31 | EUR 797.6m | ifrs-full:Assets |
| Current liabilities | At period end2019-12-31 | EUR 138.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2019-12-31 | EUR 304.2m | ifrs-full:Liabilities |
| Shareholders' equity | At period end2019-12-31 | EUR 493.5m | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001564590-20-014536. Last ingested by Listed: Nov 3, 2026, 08:40 ET. Listed shows no prices and gives no investment advice.